Our findings offer new insights into the regulation of SFXN2 in mitochondrial dysfunction through Parkin mediated ubiquitin proteasome system activity, underscoring SFXN2’s potential implications in nerodegenerative diseases, particularly PD. The gene discussed is SFXN2; the disease is glycogen storage disease VI.